Evidence map›Paper›PMID 27525548›Full record

ArticleAIDS (London, England)2016

Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Chelsea B Polis, Sharon J Phillips, Sharon L Hillier, Sharon L Achilles

Abstract readEditorialComment
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Chelsea B PolisaGuttmacher Institute, New York City, New York bDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland cDepartment of Family Medicine, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts dDepartment of Obstetrics, Gynecology, and Reproductive Sciences and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Sharon J Phillips
Sharon L Hillier
Sharon L Achilles

Funding

Microbicide Trials NetworkUM1AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2011 to 2021
$175.0M
Microbicide Trials NetworkU01AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2006 to 2010
$77.0M
Quantification of Immune Cells in Women Using ContraceptionR01AI102835 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI ACHILLES, SHARON LYNELLE · 2012 to 2016
$2.7M
Research Infrastructure for Demographic and Behavioral Population Science Dissemination CoreR24HD074034 · NICHD · GUTTMACHER INSTITUTE · PI KOST, KATHRYN L · 2013 to 2017
$462k
NIAID NIH HHS R01 AI102835NIAID NIH HHS U01 AI068633NIAID NIH HHS UM1 AI068633NICHD NIH HHS R24 HD074034
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LevonorgestrelProgestinsContraceptive Agents, FemaleHIV InfectionsHumansContraceptive Agents, FemaleLevonorgestrelProgestins

Identifiers

PMID27525548
PMCPMC5083202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.